Stay updated on Soticlestat in Dup 15q and CDKL5 Disorders Clinical Trial
Sign up to get notified when there's something new on the Soticlestat in Dup 15q and CDKL5 Disorders Clinical Trial page.

Latest updates to the Soticlestat in Dup 15q and CDKL5 Disorders Clinical Trial page
- CheckyesterdayChange DetectedA site-wide NIH notice announces updates and FAQs about a terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check8 days agoChange DetectedThe footer’s revision identifier changed from v3.7.1 to v3.7.2; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check36 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden page, replacing the usual study details view. This change reflects restricted access rather than an update to the study information itself.SummaryDifference19%

- Check43 days agoChange DetectedSponsor information has been updated to reflect the divestment of TAK-935/OV935 ownership from Takeda to Mistrau Bio, Inc. in 2026. Takeda is no longer listed as the sponsor, and a new note documents the 2026 divestment.SummaryDifference0.3%

- Check57 days agoChange DetectedThe page’s revision label updated from v3.6.5 to v3.6.6, indicating a new internal update to the page. This reflects an administrative update rather than changes to study details.SummaryDifference0.1%

Stay in the know with updates to Soticlestat in Dup 15q and CDKL5 Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Soticlestat in Dup 15q and CDKL5 Disorders Clinical Trial page.